Research News and Research

RSS

Leaders of LUH urge Congress not to overlook healthcare issues of Latinos in final healthcare reform legislation

Leaders of Latinos United for Healthcare, including Hispanic Federation, LULAC, NPRC, USHCC, National Hispanic Medical Association and Labor Council for Latin American Advancement, have sent a letter to Capitol Hill calling upon Congress to focus their attention and efforts on ensuring that the healthcare issues of Latinos are not overlooked in the final healthcare reform legislation.

12 Mar 2010

Development of promising new cancer therapies: OICR announces $1M investment

Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today announced an investment of $1 million towards the development of two new promising cancer therapies.

12 Mar 2010

Micromet prices public offering at $7.00 per share

Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.

12 Mar 2010

New micromanipulator for precise operations involving cochlear and middle ear implants

A team of engineers from the CEIT-IK4 technological centre and doctors from the University Hospital of Navarra have designed a new tool for operating on the inner ear with maximum precision, reducing the possibility of damage to the auditory function during the surgery. This is the first micromanipulator specifically for operations involving cochlear and middle ear implants, of which about a hundred are carried out in this hospital annually. Taking part in developing the new tool were four engineers from CEIT and five ear, nose and throat specialists from the University Hospital of Navarra.

12 Mar 2010

AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy

UCB today announced that the antiepileptic drug (AED) Vimpat- (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.

12 Mar 2010

Study shows experimental thyroid drug reduces cholesterol

An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.

12 Mar 2010

New method to better study prostate cancer

Van Andel Research Institute researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer. Using the model, they found that normal cells and cancer cells depend on different factors to survive, which could aid in discovering how to target cancer cells without affecting normal cells when developing treatments.

12 Mar 2010

High-intensity workout as effective as traditional types of exercise: study

The usual excuse of "lack of time" for not doing enough exercise is blown away by new research published in The Journal of Physiology.

12 Mar 2010

BDNF could someday play significant role in prevention of high blood pressure: Study

Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.

12 Mar 2010

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.

12 Mar 2010

Decision making: Replays in hippocampus part of complex process

Replaying recent events in the area of the brain called the hippocampus may have less to do with creating long-term memories, as scientists have suspected, than with an active decision-making process, suggests a new study by researchers at Carnegie Mellon University and the University of Minnesota Medical School.

12 Mar 2010

Obama renews promise to assist with Haiti's earthquake recovery during Preval's visit to the White House

"President Barack Obama on Wednesday renewed America's commitment to the recovery and reconstruction of earthquake-devastated Haiti, telling visiting President Rene Preval he knows the crisis has not passed," the Associated Press/TIME reports (Feller, 3/10).

12 Mar 2010

Neoprobe meets with FDA to review Phase 3 clinical trial results of Lymphoseek drug

Neoprobe Corporation, a diversified developer of innovative oncology and surgical diagnostic and treatment products, today announced that it recently met with the United States Food and Drug Administration to review the clinical trial results of a Phase 3 investigational new drug, Lymphoseek®.

12 Mar 2010

VisEn Medical introduces VivoTag 680 XL fluorescent dye for labeling biomolecules

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new VivoTag® 680 XL fluorescent dye for labeling biomolecules in a broad range of in vitro and in vivo imaging applications.

12 Mar 2010

$ASBMR Task Force studies link between long-term bisphosphonate usage and rare bone fractures$

ASBMR Task Force studies link between long-term bisphosphonate usage and rare bone fractures

Recent reports suggesting a link between long-term bisphosphonate usage and rare bone fractures have sparked rising concern among patients, health care professionals and the public. The American Society of Bone and Mineral Research (ASBMR) is examining this urgent clinical issue and will present its findings later this year.

12 Mar 2010

Ipsen grants Rhythm exclusive global license for melanocortin and ghrelin programs

Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen’s proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.

12 Mar 2010

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Former President Bill Clinton and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, said Wednesday at a Senate Foreign Relations Committee hearing "that U.S. investments in fighting [HIV/]AIDS, malaria and other diseases in underdeveloped nations save lives and play a vital role in improving America's image abroad," the Associated Press reports.

12 Mar 2010

Discovery of novel cellular mechanism may help develop new treatments for cancer

A research team led by the University of Colorado at Boulder has discovered a previously unknown cellular "switch" that may provide researchers with a new means of triggering programmed cell death, findings with implications for treating cancer.

12 Mar 2010

Opinions: Haiti corruption; Financial sector tax, G8 promises; Investing in women

A Washington Post editorial reflects on Haitian President Rene Preval's response to U.S. policy makers' queries "about the perils of corruption and what measures the Haitian government might devise to minimize misuse and theft of the billions of dollars in recovery assistance flowing into the country and the billions more expected" during his visit this week to Washington D.C. "Surprisingly, he seems utterly unprepared to discuss the matter," the editorial notes.

12 Mar 2010

State overhaul fears, rising costs, medical school expansions

The New York Times: "The General Assembly became the first state legislature to approve a measure that bucks any effort by President Obama and Congress to carry out a national health care overhaul in individual states." Numerous Democrats joined the Republican majority to support the measure 80-17 in the House of Delegates (3/10).

12 Mar 2010

Research News and Research

Leaders of LUH urge Congress not to overlook healthcare issues of Latinos in final healthcare reform legislation

Development of promising new cancer therapies: OICR announces $1M investment

Micromet prices public offering at $7.00 per share

New micromanipulator for precise operations involving cochlear and middle ear implants

AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy

Study shows experimental thyroid drug reduces cholesterol

New method to better study prostate cancer

High-intensity workout as effective as traditional types of exercise: study

BDNF could someday play significant role in prevention of high blood pressure: Study

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

Decision making: Replays in hippocampus part of complex process

Obama renews promise to assist with Haiti's earthquake recovery during Preval's visit to the White House

Neoprobe meets with FDA to review Phase 3 clinical trial results of Lymphoseek drug

VisEn Medical introduces VivoTag 680 XL fluorescent dye for labeling biomolecules

ASBMR Task Force studies link between long-term bisphosphonate usage and rare bone fractures

Ipsen grants Rhythm exclusive global license for melanocortin and ghrelin programs

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Discovery of novel cellular mechanism may help develop new treatments for cancer

Opinions: Haiti corruption; Financial sector tax, G8 promises; Investing in women

State overhaul fears, rising costs, medical school expansions

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence